Sarepta Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-271.51	235.24	-535.98	-703.49	-418.78	-554.13
Depreciation & Amortization	49.72	37.72	44.4	41.86	38.02	26.46
Other Amortization	-	-	-	-	-	0.45
Loss (Gain) From Sale of Assets	-	-	-102	-	-102	-107.98
Loss (Gain) From Sale of Investments	45.86	-	30.32	2.58	4.39	-
Stock-Based Compensation	143.06	184.3	182.51	233.02	113.94	108.07
Other Operating Activities	174.71	53.56	360.84	140.16	19.43	80.54
Change in Accounts Receivable	38.79	-201.66	-185.7	-61.64	-51.65	-10.46
Change in Inventory	-481.23	-395.17	-147.71	-50.78	-83.77	-60.58
Change in Accounts Payable	-21.13	110.65	-50.14	147.57	23.3	42
Change in Unearned Revenue	33.45	-32.16	-86.83	-89.24	-89.24	749.43
Change in Other Net Operating Assets	43.66	-198.26	-10.71	14.62	103.2	-166.33
Operating Cash Flow	-244.64	-205.79	-500.99	-325.35	-443.17	107.47
Capital Expenditures	-136.46	-136.96	-76.11	-30.82	-38.49	-82.2
Sale (Purchase) of Intangibles	-7.74	-10	90.76	-1.43	99.69	108.07
Investment in Securities	881.75	902.52	-180.46	-1,015	434.21	-144.09
Other Investing Activities	-	-	-	-	-	-3.5
Investing Cash Flow	737.55	755.56	-165.8	-1,047	495.41	-121.72
Long-Term Debt Issued	-	-	-	1,127	-	291.15
Long-Term Debt Repaid	-	-0.07	-	-823.23	-	-
Net Debt Issued (Repaid)	-127.52	-0.07	-	304.17	-	291.15
Issuance of Common Stock	42.11	79.53	51.25	30.04	569.33	396.01
Repurchase of Common Stock	-25.01	-	-	-	-7.77	-4.8
Other Financing Activities	30.29	45.35	73.76	-101.7	-	-0.04
Financing Cash Flow	-80.15	124.81	125	232.51	561.57	682.32
Net Cash Flow	412.77	674.58	-541.79	-1,140	613.81	668.07
Free Cash Flow	-381.1	-342.74	-577.1	-356.17	-481.66	25.26
Free Cash Flow Margin	-15.79%	-18.02%	-46.41%	-38.17%	-68.62%	4.68%
Free Cash Flow Per Share	-3.89	-3.18	-6.25	-4.07	-5.93	0.32
Cash Interest Paid	14.65	15.86	15.92	44.42	55.95	34.42
Cash Income Tax Paid	32.22	22.59	15.08	1.7	0.58	2.51
Levered Free Cash Flow	-82.47	-445.48	-330.11	-54.65	-8.7	-280.36
Unlevered Free Cash Flow	-68.86	-433.99	-316.36	-21.37	31.01	-242.89
Change in Working Capital	-386.47	-716.61	-481.09	-39.47	-98.17	554.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.